Arete Wealth Advisors’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-40,475
Closed -$1.46M – 359
2026
Q1
$1.46M Buy
40,475
+1,785
+5% +$68.5K 0.11% 184
2025
Q4
$1.49M Sell
38,690
-6,666
-15% -$251K 0.1% 196
2025
Q3
$1.64M Sell
45,356
-1,200
-3% -$41.9K 0.1% 199
2025
Q2
$1.59M Sell
46,556
-4,000
-8% -$127K 0.11% 185
2025
Q1
$1.58M Sell
50,556
-605
-1% -$19.7K 0.12% 174
2024
Q4
$1.64M Hold
51,161
– – 0.12% 179
2024
Q3
$1.66M Sell
51,161
-3,503
-6% -$110K 0.14% 150
2024
Q2
$1.7M Sell
54,664
-9,786
-15% -$292K 0.14% 147
2024
Q1
$1.91M Buy
+64,450
New +$1.83M 0.18% 136

Other funds holding QLTY

Arete Wealth Advisors's QLTY Position: Q2 2026 in Review

Arete Wealth Advisors sold out of GMO US Quality ETF (QLTY) in Q2 2026, closing a stake of 40,475 shares — an estimated $1.46M sold.

Arete Wealth Advisors first reported a position in QLTY in Q1 2024 and held it in 9 quarters. The position peaked at $1.91M in Q1 2024. 160 funds tracked by Wall St. Rank hold QLTY as of Q2 2026.

  • Arete Wealth Advisors reported no remaining GMO US Quality ETF position as of Q2 2026 after selling out during the quarter.
  • Arete Wealth Advisors sold 40,475 GMO US Quality ETF shares in Q2 2026, an estimated $1.46M.
  • Arete Wealth Advisors first reported a position in GMO US Quality ETF in Q1 2024 and held it in 9 quarters.
  • Arete Wealth Advisors's GMO US Quality ETF position peaked at $1.91M in Q1 2024.
  • 160 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q2 2026.

Based on Arete Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.